RPRX
Royalty Pharma plc · Healthcare
EVP, Research, Investments Marshall Urist sold $768K of Royalty Pharma plc
Sold$767,582
$38.38Price
20,000Shares
−12%Stake
What RPRX did after the filing
- The stock from Tue, Dec 23 open, $38.47
- +15.0%
- S&P 500, same days
- +1.0%
Measured over 30 trading days, to the Feb 6 close.
Traded Fri, Dec 19. Filed Mon, Dec 22, 4:09 PM ET, after the close. Returns use the Dec 23 open and the Feb 6 close. Not investment advice.